SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-15-000122
Filing Date
2015-02-13
Accepted
2015-02-13 15:08:57
Documents
1
Group Members
ALEX ZISSONERIC AGUIARJAMES THOMASPETER MCNERNEYTHOMAS MCNERNEY & PARTNERS II LLCTMP ASSOCIATES II L.P.TMP NOMINEE II LLC

Document Format Files

Seq Description Document Type Size
1 AUSPEX PHARMACEUTICALS, INC. - AMEND. NO. 1 auspex-sch13da_17765.htm SC 13D/A 362079
  Complete submission text file 0001072613-15-000122.txt   363825
Mailing Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402
Business Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402 612-456-8660
Thomas, McNerney & Partners II L.P. (Filed by) CIK: 0001369574 (see all company filings)

IRS No.: 721618589
Type: SC 13D/A

Mailing Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037
Business Address 3333 N. TORREY PINES COURT SUITE 400 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Subject) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87930 | Film No.: 15613278
SIC: 2834 Pharmaceutical Preparations